Fei Xiong
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
-
- Epigenetics and DNA Methylation 8
- Cancer-related gene regulation 5
- RNA modifications and cancer 4
-
- Pancreatic and Hepatic Oncology Research 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 10
-
- Gallbladder and Bile Duct Disorders 3
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Journal of Controlled Release (1 paper)Advanced Science (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Fei Xiong
37 papers receiving 525 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 117
- Molecular Biology 306
- Immunology 75
- Oncology 94
- Biochemistry 17
Countries citing papers authored by Fei Xiong
This map shows the geographic impact of Fei Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Xiong more than expected).
Fields of papers citing papers by Fei Xiong
This network shows the impact of papers produced by Fei Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Xiong. The network helps show where Fei Xiong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fei Xiong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 17 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 35 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 24 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 10 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 13 | |
| 17 | 2020 | 28 | |
| 18 | 2019 | 20 | |
| 19 | 2017 | 2 | |
| 20 | Clinical and genetic characteristics for the Urofacial Syndrome (UFS). | 2014 | 8 |
About Fei Xiong
Fei Xiong is a scholar working on Cancer Research, Biochemistry and Surgery, having authored 39 papers that have together received 526 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Epigenetics and DNA Methylation (8 papers), MicroRNA in disease regulation (5 papers), Cancer-related gene regulation (5 papers), Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Gallbladder and Bile Duct Disorders (3 papers). The work is most often cited by research in Cancer Research (117 citations), Molecular Biology (306 citations) and Immunology (75 citations). Fei Xiong has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yongjun Chen, Guanhua Wu, Wenzheng Liu, Bing Wang, Junsheng Chen, Qi Wang, Junbin Chen, Longying Zha, Da Wang and Zhongdaixi Zheng. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Controlled Release and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.